XML 35 R25.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Fair Value Measurements (Tables) | 3 Months Ended
--- | ---
Sep. 30, 2022
Notes Tables |
Schedule of information by level for financial assets and liabilities that are measured at fair value on a recurring basis | The following tables provide information by level for financial assets and liabilities that are measured at fair value on a recurring basis (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Total |  | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | carrying | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | value as of | ​ | Fair Value Measurements Using
​ | ​ | September 30, | ​ | Inputs Considered as
​ | ​ | 2022 | ​ | Level 1 | ​ | Level 2 | ​ | Level 3
​ |  | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Assets |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |
Exchange traded securities(1) | ​ | $ | 23,318 | ​ | $ | 23,318 | ​ | $ | — | ​ | $ | —
Certificates of deposit(2) | ​ |  | 14,500 | ​ |  | 14,500 | ​ |  | — | ​ |  | —
Derivative instruments - cash flow hedges | ​ |  | 16,685 | ​ |  | — | ​ |  | 16,685 | ​ |  | —
Total assets | ​ | $ | 54,503 | ​ | $ | 37,818 | ​ | $ | 16,685 | ​ | $ | —
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Liabilities | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |
Contingent consideration | ​ | $ | 15,500 | ​ | $ | — | ​ | $ | — | ​ | $ | 15,500
Total liabilities | ​ | $ | 15,500 | ​ | $ | — | ​ | $ | — | ​ | $ | 15,500
​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Total |  | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | carrying | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | value as of | ​ | Fair Value Measurements Using
​ | ​ | June 30, | ​ | Inputs Considered as
​ |  | 2022 |  | Level 1 |  | Level 2 |  | Level 3
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Assets |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |
Exchange traded securities(1) | ​ | $ | 59,962 | ​ | $ | 59,962 | ​ | $ | — | ​ | $ | —
Certificates of deposit(2) | ​ |  | 14,500 | ​ |  | 14,500 | ​ |  | — | ​ |  | —
Derivative instruments - cash flow hedges | ​ |  | 11,026 | ​ |  | — | ​ |  | 11,026 | ​ |  | —
Total assets | ​ | $ | 85,488 | ​ | $ | 74,462 | ​ | $ | 11,026 | ​ | $ | —
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Liabilities | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |
Contingent consideration | ​ | $ | 5,000 | ​ | $ | — | ​ | $ | — | ​ | $ | 5,000
Derivative instruments - cash flow hedges | ​ |  | 476 | ​ |  | — | ​ |  | 476 | ​ |  | —
Total liabilities | ​ | $ | 5,476 | ​ | $ | — | ​ | $ | 476 | ​ | $ | 5,000
​
(1) | Included in available-for-sale investments on the balance sheet. During the quarter ended September 30, 2022, the Company sold all of its outstanding shares of ChemoCentryx Inc (CCXI). The cost basis and fair value of the Company’s available-for-sale equity investment in CCXI was $6.6 million and $36.0 million at June 30, 2022, respectively. The cost basis and fair value of the exchange traded investment grade bond funds as of September 30, 2022 was $25.0 million and $23.3 million, respectively. The cost basis and fair value of the exchange traded investment grade bond funds as of June 30, 2022 was $25.0 million and $23.9 million, respectively.
​
(2) | Included in available-for-sale investments on the balance sheet. The certificates of deposit have contractual maturity dates within one year.
Schedule of the reconciliation of the liability measured at fair value on a recurring basis using significant unobservable inputs (Level 3) | The following table presents a reconciliation of the liability measured at fair value on a recurring basis using significant unobservable inputs (Level 3) (in thousands): ​
​ | ​ | ​ | ​ | ​
​ |  | Quarter Ended | ​
​ | ​ | September 30, | ​
​ | ​ | 2022 | ​
​ | ​ | ​ | ​ | ​
Fair value at the beginning of period | ​ | $ | 5,000 | ​
Change in fair value of contingent consideration | ​ |  | (100) | ​
Additions | ​ |  | 10,600 | ​
Payments | ​ |  | — | ​
Fair value at the end of period | ​ | $ | 15,500 | ​
​

X
- Definition Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258 + Details
Name: | us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258 + Details
Name: | us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_TableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration